Lactylation-driven MVP upregulation boosts immunotherapy resistance by inhibiting PD-L1 degradation in hepatocellular carcinoma

下调和上调 肝细胞癌 免疫疗法 封锁 癌症研究 医学 PD-L1 降级(电信) 癌症免疫疗法 组蛋白 后天抵抗 程序性细胞死亡 抑制器 T细胞 肿瘤微环境 细胞培养 细胞 肝癌
作者
Shuang Liu,Yihui Pan,Wenjian Liu,Xiaoyun Bu,Ruonan Shao,Qi Wang,Jun Wu,Chen Wu,Wenwei Hu,Jun Xu,Changping Wu,Jingting Jiang
出处
期刊:Journal for ImmunoTherapy of Cancer [BMJ]
卷期号:13 (9): e012230-e012230 被引量:31
标识
DOI:10.1136/jitc-2025-012230
摘要

BACKGROUND: Hepatocellular carcinoma (HCC) is a prevalent malignancy and the third leading cause of cancer-related mortality worldwide. Immune checkpoint inhibitors (ICIs) have emerged as first-line therapies for advanced HCC, substantially improving clinical outcomes. However, resistance to ICIs remains a major therapeutic challenge. Lactylation, a recently identified post-translational modification, has been implicated in tumor progression, although its role in ICIs resistance in HCC remains unclear. METHODS: Cytotoxicity assays, flow cytometry and orthotopic HCC mouse model were used to evaluate the effects of lactylation in remodeling the immune microenvironment. Chromatin immunoprecipitation sequencing and RNA sequencing were employed to identify lactylation-regulated gene profiles. Programmed cell death-ligand 1 (PD-L1) protein degradation was assayed by cycloheximide-chase analysis and ubiquitination assay. Interactions between major vault protein (MVP) and β-transducin repeat-containing protein (β-TrCP) were analyzed by co-immunoprecipitation experiments. Site-directed mutagenesis and truncation mutants were designed to determine binding sites of MVP-β-TrCP complex. RESULTS: T cell-mediated antitumor immunity. Elevated MVP expression is associated with resistance to checkpoint blockade therapy. Mechanistic studies reveal that histone lactylation-induced MVP upregulation stabilizes PD-L1 by preventing β-TrCP-mediated proteasomal degradation. Pharmacological inhibition of lactylation restores ICIs sensitivity in orthotopic HCC mouse models. CONCLUSIONS: Our findings demonstrate that histone lactylation promotes ICIs resistance via MVP-dependent PD-L1 stabilization. Therefore, targeting lactylation in combination with programmed cell death protein-1/PD-L1 blockade offers a promising strategy to overcome immunotherapy resistance in HCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
dai完成签到,获得积分10
1秒前
ljx发布了新的文献求助10
1秒前
zhouzheng发布了新的文献求助10
1秒前
ddl发布了新的文献求助10
2秒前
kkk发布了新的文献求助10
3秒前
火山完成签到 ,获得积分0
3秒前
十年HLX完成签到,获得积分10
3秒前
瑰慈完成签到,获得积分10
3秒前
就不7香菜完成签到,获得积分10
4秒前
4秒前
华仔的应助被正直的语海采纳,获得10
4秒前
xjh的应助被咩咩羊采纳,获得10
5秒前
5秒前
充电宝的应助被wuming7890采纳,获得10
5秒前
Ralph发布了新的文献求助10
5秒前
满山猴子我腚最红完成签到,获得积分10
6秒前
所所的应助被YY采纳,获得10
6秒前
天天快乐的应助被科研通管家采纳,获得10
7秒前
7秒前
在水一方的应助被科研通管家采纳,获得30
7秒前
东方鸾完成签到,获得积分10
7秒前
小马甲的应助被科研通管家采纳,获得10
7秒前
mzy关注了科研通微信公众号
8秒前
奋斗人雄完成签到,获得积分0
8秒前
Jasper的应助被科研通管家采纳,获得10
8秒前
8秒前
8秒前
韶芸遥发布了新的文献求助10
8秒前
乐乐的应助被科研通管家采纳,获得10
8秒前
平安小友完成签到,获得积分10
8秒前
彭于晏的应助被科研通管家采纳,获得10
8秒前
搜集达人的应助被科研通管家采纳,获得20
8秒前
JamesPei的应助被科研通管家采纳,获得10
9秒前
大模型的应助被科研通管家采纳,获得10
9秒前
FashionBoy的应助被科研通管家采纳,获得10
9秒前
xjh的应助被ganlixuan采纳,获得30
9秒前
is的应助被YANG采纳,获得10
9秒前
bkagyin的应助被科研通管家采纳,获得10
9秒前
wy.he的应助被科研通管家采纳,获得20
9秒前
nansang完成签到,获得积分10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153299
求助须知:如何正确求助?哪些是违规求助? 9549963
关于积分的说明 21695977
捐赠科研通 7741796
什么是DOI,文献DOI怎么找? 3425434
关于科研通互助平台的介绍 2550601
邀请新用户注册赠送积分活动 2469116